| Smooth muscle myosin expression, isoform composition, and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes. | |
| | |
MedLine Citation:
|
PMID: 21917637 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Diabetes mellitus (DM) is a quite common chronic disease, and the prevalence of erectile dysfunction (ED) is three times higher in this large population. Although diabetes-related ED has been studied extensively, the actin-myosin contractile apparatus was not examined. The mRNAs encoding smooth muscle myosin (SMM) heavy chains (MHC) and essential light chains (LC(17)) exist as several different alternatively spliced isoforms with distinct contractile properties. Recently, we provided novel data that blebbistatin (BLEB), a specific myosin II inhibitor, potently relaxed corpus cavernosum smooth muscle (CCSM). In this study, we examine whether diabetes alters SMM expression, alternative splicing, and/or functional activities, including sensitivity to BLEB. By using streptozotocin (STZ)-induced 2-mo diabetic rats, functional activities were tested in vivo by intracavernous pressure (ICP) recording during cavernous nerve stimulation and in vitro via organ bath contractility studies. SMM isoform composition was analyzed by competitive RT-PCR and total SMM, myocardin, and embryonic SMM (SMemb) expression by real-time RT-PCR. Results revealed that the blood glucose level of STZ rats was 407.0 vs. 129.5 mg/dl (control). STZ rats exhibited ED confirmed by significantly increased CCSM contractile response to phenylephrine and decreased ICP response. For STZ rats, SM-B, LC(17a) and SM2 isoforms, total SMM, and myocardin expression increased, whereas SM-A, LC(17b), and SM1 isoforms were decreased, with SMemb unchanged. BLEB was significantly more effective in relaxing STZ CCSM both in vitro and in vivo. Thus we demonstrated a novel diabetes-specific effect on alternative splicing of the SMM heavy chain and essential light chain genes to a SMM isoform composition favoring a heightened contractility and ED. A switch to a more contractile phenotype was supported further by total SMM expression increase. Moreover, the change in CCSM phenotype was associated with an increased sensitivity to BLEB, which may serve as a novel pharmacotherapy for ED. |
| | |
Authors:
|
Xinhua Zhang; Nirmala D Kanika; Arnold Melman; Michael E DiSanto |
Related Documents
:
|
20659817 - Cutaneous sympathetic neural responses to body cooling in type 2 diabetes mellitus. 2850927 - Influence of the endothelium on contractile responses of arteries from diabetic rats. 11685657 - Altered gap junction activity in cardiovascular tissues of diabetes. 12048137 - Leukocyte count and vascular function in type 2 diabetic subjects with treated hyperten... 3279967 - Variations in lipoproteins, hormones and blood glucose during the early acute phase of ... 16989067 - Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood... |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, N.I.H., Extramural Date: 2011-09-13 |
Journal Detail:
|
Title: American journal of physiology. Endocrinology and metabolism Volume: 302 ISSN: 1522-1555 ISO Abbreviation: Am. J. Physiol. Endocrinol. Metab. Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2011-12-19 Completed Date: 2012-02-14 Revised Date: 2012-04-20 |
Medline Journal Info:
|
Nlm Unique ID: 100901226 Medline TA: Am J Physiol Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: E32-42 Citation Subset: IM |
Affiliation:
|
Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Alternative Splicing Animals Diabetes Mellitus, Type 1 / complications, metabolism*, physiopathology* Drug Resistance Enzyme Inhibitors / pharmacology Erectile Dysfunction / complications, drug therapy, metabolism*, physiopathology* Gene Expression Regulation Heterocyclic Compounds with 4 or More Rings / pharmacology Male Muscle Contraction / drug effects Muscle, Smooth / drug effects, metabolism, physiopathology Myosin Heavy Chains / genetics, metabolism Myosin Light Chains / genetics, metabolism Myosin Type II / antagonists & inhibitors Nuclear Proteins / genetics, metabolism Penis / drug effects, innervation, metabolism*, physiopathology* Protein Isoforms / genetics, metabolism RNA, Messenger / metabolism Rats Rats, Inbred F344 Smooth Muscle Myosins / genetics, metabolism* Streptozocin / toxicity Trans-Activators / genetics, metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
5-R01-DK-077116/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 0/Heterocyclic Compounds with 4 or More Rings; 0/Myosin Heavy Chains; 0/Myosin Light Chains; 0/Nuclear Proteins; 0/Protein Isoforms; 0/RNA, Messenger; 0/Trans-Activators; 0/blebbistatin; 0/myocardin; 18883-66-4/Streptozocin; EC 3.6.1.-/Myosin Type II; EC 3.6.1.-/Smooth Muscle Myosins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandi...
Next Document: Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implication...